Caglayan V, Onen E, Avci S, Sambel M, Kilic M, Oner S, Aydos MM, Yıldız HE. Lymphocyte-to-monocyte ratio is a valuable marker to predict prostate cancer in patients with prostate specific antigen between 4 and 10 ng/dl. Arch Ital Urol Androl [Internet]. 2019 Jan. 17 [cited 2024 Nov. 24];90(4):270-5. Available from: https://www.pagepressjournals.org/aiua/article/view/aiua.2018.4.270